Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far. If you were like us and stayed up to watch the Democratic presidential debate, you may want an extra cup of stimulation this morning. As noted below, there were no fireworks, at least when it came to the pharmaceutical industry. But as always, there is much else to track. So please feel free to dig into the tidbits we have assembled. Hope your day goes well and keep in touch…
During the Democratic presidential debate, both Hillary Clinton and Bernie Sanders listed drug makers among the enemies they’ve made; The National Comprehensive Cancer Network plans to provide patients with guidance about the cost of drugs used in their treatment; and Johnson & Johnson believes that tests showing the ability of Jardiance, an Eli Lilly diabetes drug, to save lives is a benefit that will likely be seen in the entire class of SGLT-2 drugs;.